LWAM
MLAB icon

Legacy Wealth Asset Management’s Mesa Laboratories MLAB Stock Holding History

Legacy Wealth Asset Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-698
Closed -$229K – 336
2021
Q4 		$229K Sell
698
-6
-0.9% -$1.88K 0.08% 288
2021
Q3 		$213K Sell
704
-310
-31% -$88.1K 0.1% 279
2021
Q2 		$275K Sell
1,014
-378
-27% -$95.9K 0.12% 256
2021
Q1 		$339K Sell
1,392
-87
-6% -$23.9K 0.16% 228
2020
Q4 		$424K Buy
+1,479
New +$407K 0.21% 183

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Legacy Wealth Asset Management's MLAB Position: Q1 2022 in Review

Legacy Wealth Asset Management sold out of Mesa Laboratories (MLAB) in Q1 2022, closing a stake of 698 shares — an estimated $229K sold.

Legacy Wealth Asset Management first reported a position in MLAB in Q4 2020 and held it in 5 quarters. The position peaked at $424K in Q4 2020. 175 funds tracked by Wall St. Rank hold MLAB as of Q1 2022.

  • Legacy Wealth Asset Management reported no remaining Mesa Laboratories position as of Q1 2022 after selling out during the quarter.
  • Legacy Wealth Asset Management sold 698 Mesa Laboratories shares in Q1 2022, an estimated $229K.
  • Legacy Wealth Asset Management first reported a position in Mesa Laboratories in Q4 2020 and held it in 5 quarters.
  • Legacy Wealth Asset Management's Mesa Laboratories position peaked at $424K in Q4 2020.
  • 175 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2022.

Based on Legacy Wealth Asset Management's 13F filing for Q1 2022, filed 12 May 2022.